Biofluid-Derived Exosomes

Biofluid-derived exosomes are released by cells in bodily fluids such as blood, urine, and CSF. They are enriched with proteins, lipids, and nucleic acids, and their contents reflect the health and status of their parent cells. As exosomes act as carriers for cell-to-cell communication, transferring information and cargo between cells, they have garnered significant attention as potential biomarkers for various diseases and as therapeutic agents. Particularly, exosomes derived from human biofluids are increasingly recognized and being explored as biomarkers for disease detection and monitoring, as well as therapeutic agents for drug delivery and regenerative medicine.
AcceGen provides high-quality Human Biofluid-Derived Exosomes, generated from different kinds of biofluid including plasma, serum, urine, saliva, CSF, breast milk, and ascites, each offering unique opportunities for research and clinical applications. For example, circulating exosomes in blood carry information about various tissues and organs, making them valuable for detecting diseases. Exosomes derived from urine can reflect kidney health and function, and are being investigated as biomarkers for kidney diseases such as CKD. Exosomes in CSF can provide insights into CNS diseases and are being studied for their role in neurodegenerative disorders.
These exosomes allow researchers to explore the molecular cargo in biofluids, advancing our ability to detect and monitor diseases in a non-invasive manner and opening new avenues for diagnostic and therapeutic applications.
In essence, biofluid-derived exosomes are a fascinating area of research with the potential to revolutionize healthcare, offering insights into disease mechanisms, biomarkers for early diagnosis, and new therapeutic strategies, offering a platform for personalized medicine.